Bayer is boosting its precision oncology efforts with a molecular database from health tech firm ConcertAI.  | Bayer is ...

The expansion strengthens Bayer’s ability to deliver health-focused products more efficiently across North America.

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic ...

Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug molecules ...

ConcertAI has announced an agreement that will allow Bayer to utilise its Translational360 and AI software-as-a-service (SaaS ...

Two prominent German investors voiced exasperation over Bayer AG’s recurring struggles, demanding a clearer path out of the ...

talk with your doctor or pharmacist or view the drug’s prescribing information. If these effects are mild, they may go away within a few days or a couple of weeks. If they’re more severe or ...

The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.

Bayer’s Myerstown site has a history dating back over 75 years, and it has now grown to become the largest manufacturing site in Bayer’s Consumer Health network globally, producing brands such as ...